Syed Mohsin Saghir1, Banreet Singh Dhindsa1, Sarav Gunjit Singh Daid2, Harmeet S Mashiana3, Amaninder Dhaliwal3, Chad Cross4, Shailender Singh3, Ishfaq Bhat3, Gordon V Ohning5, Douglas G Adler6. 1. Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, NV, USA. 2. Department of Internal Medicine, Roger Williams Medical Center, Providence, RI, USA. 3. Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE, USA. 4. Department of Biostatistics and Epidemiology, University of Nevada, Las Vegas, NV, USA. 5. Department of Gastroenterology and Hepatology, University of Nevada Las Vegas School of Medicine, Las Vegas, NV, USA. 6. Huntsman Cancer Center, University of Utah School of Medicine, Salt Lake City, UT, USA.
Abstract
BACKGROUND AND OBJECTIVES: Needle-based confocal laser endomicroscopy (nCLE) is a procedure in which an AQ-Flex nCLE mini-probe is passed through an EUS-FNA needle into a pancreatic lesion to enable subsurface in vivo tissue analysis. In this study, we conducted a systematic review and meta-analysis of nCLE for the diagnosis of pancreatic lesions. MATERIALS AND METHODS: We conducted a comprehensive search of several databases and conference proceedings, including PubMed, EMBASE, Google-Scholar, MEDLINE, SCOPUS, and Web of Science databases (earliest inception to March 2020). The primary outcomes assessed the pooled rate of diagnostic accuracy for nCLE and the secondary outcomes assessed the pooled rate of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and adverse events (AE) of nCLE to diagnose premalignant/malignant pancreatic lesions. RESULTS: Eleven studies on 443 patients were included in our analysis. The pooled rate of diagnostic accuracy of EUS nCLE was 83% (95 confidence interval [CI] = 79-87; I 2 = 0). The pooled rate of sensitivity, specificity, PPV and NPV of EUS nCLE was 85.29% (95% CI = 76.9-93.68; I 2 = 85%), 90.49% (95% CI = 82.24-98.74; I 2 = 64%), 94.15% (95% CI = 88.55-99.76; I 2 = 68%), and 73.44% (95% CI = 60.16-86.72; I 2 = 93%), respectively. The total AE rate was 5.41% (±5.92) with postprocedure pancreatitis being the most common AE at 2.28% (±3.73). CONCLUSION: In summary, this study highlights the rate of diagnostic accuracy, sensitivity, specificity, and PPV for distinguishing premalignant/malignant lesions. Pancreatic lesions need to be further defined with more validation studies to characterize CLE diagnosis criteria and to evaluate its use as an adjunct to EUS-FNA.
BACKGROUND AND OBJECTIVES: Needle-based confocal laser endomicroscopy (nCLE) is a procedure in which an AQ-Flex nCLE mini-probe is passed through an EUS-FNA needle into a pancreatic lesion to enable subsurface in vivo tissue analysis. In this study, we conducted a systematic review and meta-analysis of nCLE for the diagnosis of pancreatic lesions. MATERIALS AND METHODS: We conducted a comprehensive search of several databases and conference proceedings, including PubMed, EMBASE, Google-Scholar, MEDLINE, SCOPUS, and Web of Science databases (earliest inception to March 2020). The primary outcomes assessed the pooled rate of diagnostic accuracy for nCLE and the secondary outcomes assessed the pooled rate of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and adverse events (AE) of nCLE to diagnose premalignant/malignant pancreatic lesions. RESULTS: Eleven studies on 443 patients were included in our analysis. The pooled rate of diagnostic accuracy of EUS nCLE was 83% (95 confidence interval [CI] = 79-87; I 2 = 0). The pooled rate of sensitivity, specificity, PPV and NPV of EUS nCLE was 85.29% (95% CI = 76.9-93.68; I 2 = 85%), 90.49% (95% CI = 82.24-98.74; I 2 = 64%), 94.15% (95% CI = 88.55-99.76; I 2 = 68%), and 73.44% (95% CI = 60.16-86.72; I 2 = 93%), respectively. The total AE rate was 5.41% (±5.92) with postprocedure pancreatitis being the most common AE at 2.28% (±3.73). CONCLUSION: In summary, this study highlights the rate of diagnostic accuracy, sensitivity, specificity, and PPV for distinguishing premalignant/malignant lesions. Pancreatic lesions need to be further defined with more validation studies to characterize CLE diagnosis criteria and to evaluate its use as an adjunct to EUS-FNA.
Authors: Koen de Jong; C Yung Nio; John J Hermans; Marcel G Dijkgraaf; Dirk J Gouma; Casper H J van Eijck; Eddy van Heel; Gunter Klass; Paul Fockens; Marco J Bruno Journal: Clin Gastroenterol Hepatol Date: 2010-06-01 Impact factor: 11.382
Authors: Gordon H Guyatt; Andrew D Oxman; Regina Kunz; James Woodcock; Jan Brozek; Mark Helfand; Pablo Alonso-Coello; Paul Glasziou; Roman Jaeschke; Elie A Akl; Susan Norris; Gunn Vist; Philipp Dahm; Vijay K Shukla; Julian Higgins; Yngve Falck-Ytter; Holger J Schünemann Journal: J Clin Epidemiol Date: 2011-07-31 Impact factor: 6.437
Authors: Vani J A Konda; Alexander Meining; Laith H Jamil; Marc Giovannini; Joo Ha Hwang; Michael B Wallace; Kenneth J Chang; Uzma D Siddiqui; John Hart; Simon K Lo; Michael D Saunders; Harry R Aslanian; Kirsten Wroblewski; Irving Waxman Journal: Endoscopy Date: 2013-10-25 Impact factor: 10.093
Authors: Somashekar G Krishna; Benjamin Swanson; Phil A Hart; Samer El-Dika; Jon P Walker; Sean T McCarthy; Ahmad Malli; Zarine K Shah; Darwin L Conwell Journal: Endosc Int Open Date: 2016-09-30